Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071831 · ClinicalTrials.gov registry record
RETRO Study (RETrograde Renal Access Outcomes)
A clinical trial of Renal Stones, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT07071831: Recruiting study of Renal Stones, sponsored by University of Kansas Medical Center.
NCT07071831 is a study of Renal Stones that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 150 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07071831, a study of Renal Stones, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous nephrolithotomy as part of their regular care will be asked to participate.
Primary Outcome
The proportion of successful renal access was compared to the renal access attempts (e.g. 100 success attempts/110 attempts).
Conditions Studied
Interventions
- DEVICE RetroPerc®
Study Locations (2)
Florida
- University of South Florida - Tampa
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2026-12 |
What NCT07071831 shows while recruiting
NCT07071831 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Renal Stones appearing as the primary indexed condition, and to 1 intervention - of which RetroPerc® is the first listed.
NCT07071831 reports a single indexed study location in Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT07071831 about?
NCT07071831 is a clinical study titled "RETRO Study (RETrograde Renal Access Outcomes)". The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous...
What is the current status of trial NCT07071831?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-12-06. Estimated completion is 2026-12.
What conditions does trial NCT07071831 study?
This clinical trial studies the following conditions: Renal Stones.
What interventions are being tested in trial NCT07071831?
The interventions under investigation include: RetroPerc® (DEVICE).
Who is sponsoring clinical trial NCT07071831?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07071831 being conducted?
This trial has 2 study locations across Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI